Search
site map
IP Handbook Blog
Your source for expert commentary on IP management issues.
Go to the blog
About
MIHR
PIPRA
Fiocruz, Brazil
bioDevelopments- Institute
|
NEAGLEY, Clinton H
Clinton H. Neagley is Associate Director of Technology Transfer Services at the University of California, Davis. His responsibilities include patenting and licensing inventions in the fields of agriculture, biotechnology, chemistry, and physical science, as well as assisting academic researchers on intellectual property matters. Before joining U.C. Davis, Dr. Neagley was Chief Patent Counsel and Director of Licensing for DNA Plant Technology Corporation (DNAP), where he was responsible for intellectual property and technology contracts, managing the patent portfolio, and licensing and freedom-to-operate assessment. Prior to his position at DNAP, Dr. Neagley spent ten years with the New York City intellectual property law firm of Davis Hoxie Faithfull & Hapgood, where he worked on litigation, licensing, and patent prosecution. As a partner at Davis Hoxie, he played a lead role in the biotechnology group, representing clients from large established companies, start-up companies, and universities. He has lectured and published on many topics of patent law. He is a member of the California and New York Bars and is a registered Patent Attorney. Dr. Neagley has a J.D. from Cornell Law School and a Ph.D. in Chemistry from the University of California, Davis.
Abstract
Patent Licensing for Small Agricultural Biotechnology Companies
Abstract:
A small agricultural biotechnology (agri-biotech) company needs to establish a strong IP portfolio. Such a portfolio provides a foundation for R&D, encourages outside investment and funding, and supports product commercialization. An important step in establishing an IP portfolio is in-licensing patent rights from third-party patent holders. Nonexclusive licenses typically give a company freedom to operate and open up the possibility of creating commercializable products. Exclusive licenses give a company an exclusive position for commercialization under the patents in question.
This chapter discusses in-licensing as it applies to small agri-biotech companies. It describes the types of technologies that may be subject to in-licensing, the procedures attendant upon in-licensing, and the terms that may be delineated by in-licenses.
|